Clifton R. Laduane has bought 1,725 shares of Zevra Therapeutics, Inc. [null] at $4.15 a share.
Zevra Therapeutics, Inc. [null] disclosed in an SEC Form 4 submission Friday, March 10, 2023 that the deal increased Clifton R. Laduane's holding in the company to 11,002.
Zevra Therapeutics, Inc. [null] is a Pharmaceutical Preparations company based in Delaware.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.